In analysis of molecular mechanisms, NAC treatment attenuated ROS-mediated or TNFα-mediated activation of MAPKs, including ERK1/2, p38, and JNK, and NF-κB signaling in AF cells in vitro. Here, MAPK3 is linked to atrial fibrillation.